Survey on Knowledge, Attitudes, and Training Needs of Italian Residents on Genetic Tests for Hereditary Breast and Colorectal Cancer
Table 4
Attitudes of residents () towards genetic testing for breast and colorectal cancer.
Number of responders to the question
% of correct answers
CI 95%
(1) Genetic tests for breast cancer and colorectal cancer increase the chances of prevention opportunities (agree, uncertain, disagree)
355
85.1
80.9–88.6
(2) Genetic tests that able to identify an increased risk of developing breast or colorectal cancer should be performed even if there are no preventive and/or curative interventions of proven efficacy (agree, uncertain, disagree)
352
48.3
43.0–53.6
(3) Genetic tests for breast cancer or colorectal cancer should be performed only if economical evaluations show cost effectiveness ratios favorable compared to alternative health interventions (agree, uncertain, disagree)
354
46.3
41.0–51.7
(4) Authoritative and evidence-based guidelines are needed for the appropriate use of genetic tests for breast cancer and colorectal cancer (agree, uncertain, disagree)
355
92.4
89.1–94.9
(5) Genetic tests for breast and colorectal cancer should be performed without genetic counseling informing patients of the benefits and risks of the tests (agree, uncertain, disagree)
355
76.9
72.2–81.2
(6) Genetic tests for breast and colorectal cancer can contribute efficaciously to health promotion and cancer prevention only if included in wider strategies taking into account the other available health interventions (agree, uncertain, disagree)
354
83.1
78.7–86.8
(7) The implementation of genetic tests for breast and colorectal cancer, being a medical matter, should not take into account ethical, legal and social implications (agree, uncertain, disagree)
